Recently, we also showed that Oct4 induced by chemotherapeutic drugs can enhance the acquisition of CSC phenotypes and drug resistance in bladder cancer, and that Oct expression is positively correlated with tumor recurrence [16]. This evidence concerns the gene POU5F1 and urinary bladder carcinoma.